BSRT Advisory Panel member Christopher Greenwald’s opening remarks highlighted the top-of-mind sustainability topics for the capital markets today, including AI scaling, Biopharma Innovation, Access to Medicines, and Human Capital, as well as systemic risks arising from Climate and Nature, and AMR. The conversation, with over 20 biopharma and investor representatives, also underlined business prerequisites for long-term value creation, such as solid Governance.
